Bispecific GD2 x B7-H3 Antibody Improves Tumor Targeting and Reduces Toxicity while Maintaining Efficacy for Neuroblastoma
Amy K. Erbe, Arika S. Feils, Alina A. Hampton, Zachary T. Rosenkrans, Mildred A. R. Felder, Jessica M. Wiwczar, Daniel J. Gerhardt, Mark R. Bercher, Belinda B. Wenke, Callie Haertle, Mackenzie Heck, Sabrina N. VandenHeuvel, Lizzie Frankel, Megan Nielsen, Dan Spiegelman, , Paul M. Sondel
bioRxiv · May 23, 2024 · PreprintCancer Biology